CVS Group plc, a leading provider of integrated veterinary services in the UK, announced that Joanne Shaw, a Non-executive Director, purchased 959 ordinary shares of 0.2p each in the Company on 20 June. This transaction has increased Joanne Shaw's total interest in the Company to 1,548 Ordinary Shares, representing 0.002 per cent of the total voting rights of the Company. The notification, made in accordance with the UK Market Abuse Regulation, provides further detail on the transaction.
The company's contacts for further information were also provided, including CVS Group plc's CEO and Company Secretary, as well as the Nominated Adviser & Broker and Joint Broker. The notification and public disclosure of the transaction by persons discharging managerial responsibilities and persons closely associated with them were also outlined in the announcement.
The details of the transaction included the nature of the transaction (on-market purchase), the price (1,042.27 pence) and volume (959 shares), and the date of the transaction (20 June 2024). The notification also included the name of the person discharging managerial responsibilities (Joanne Shaw) and the issuer (CVS Group plc), along with the necessary identification codes and details.
This announcement provides transparency regarding the increase in Joanne Shaw's stake in CVS Group plc, offering insight into the company's internal dealings and the actions of its key personnel.